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With the advent of the new access and waiting-time
standard for ﬁrst-episode psychosis published by NHS
England in February 2015,1 there is now a deﬁnite move
to adopt service models aimed at preventing transition to
psychosis in vulnerable individuals, as originally developed
in 1994 by the Personal Assistance and Crisis Evaluation
clinic in Melbourne.2 There is an expectation that early
intervention in psychosis services will now also offer
interventions for at-risk mental state for psychosis
(ARMS), based on our evolving understanding of best
practice in this area.
This move is exciting for a number of reasons. It
represents a commitment from the Government to support
mental health service development and reform, especially
preventive approaches, at a time when many services are
experiencing cuts. Cost-effectiveness of ARMS services has
been demonstrated.3 Second, as a treatment paradigm the
preventive strategy represents a possibility that we can alter
the trajectory of a potentially serious condition and improve
outcomes in all domains, including symptoms and
functioning. Third, we may be able to use, at an earlier
stage of illness, more benign treatments that are potentially
less costly, less stigmatising and better tolerated.2 This
preventive model also represents an opportunity to broaden
treatment paradigms within mental health, not just for
psychosis but for other disorders, ﬁtting perfectly with
another current health development strategy - low-stigma,
accessible and responsive youth mental health services.
Debate continues as to whether such services are
appropriately placed within established early intervention
for psychosis or whether new, dedicated teams with a more
public health emphasis should be created. However, existing
services have expertise in both deﬁning ﬁrst-episode
psychosis thresholds and offering relevant clinical support
packages for both ARMS and ﬁrst-episode psychosis.4
The criteria commonly used in the UK for ARMS depend
on the presenting clinical features, relative functional
impairment and help-seeking.2 Consistent quantiﬁcation
of distress relating to these features is currently lacking. It
also remains unclear how these clinical risk features differ
from more widespread psychotic phenomena in the general
population. Psychotic experiences in non-help-seeking
populations appear relatively common, affecting about
5%,5 and higher in child and adolescent samples;6 there
is apparent sharing of aetiological risk factors with
schizophrenia. Clinical outcomes of this non-help-seeking
group are unknown. Psychosis transition threshold is
commonly deﬁned by three Positive and Negative Syndrome
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Summary Expansion of early intervention services to identify and clinically manage
at-risk mental state for psychosis has been recently commissioned by NHS England.
Although this is a welcome development for preventive psychiatry, further clarity is
required on thresholds for deﬁnition of such risk states and their ability to predict
subsequent outcomes. Intervention studies for these risk states have demonstrated
that a variety of interventions, including those with fewer adverse effects than
antipsychotic medication, may potentially be effective but they should be interpreted
with caution.
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Scale items (delusions, hallucinations or conceptual
disorganisation) achieving adequate severity for at least
7 days,7 but such psychosis thresholds are not without
controversy.8 The large majority of those identiﬁed as
ARMS do not cross this severity threshold within 3 years of
follow-up, although many remain functionally impaired or
develop other disorders.2 Whether other transition criteria,
or modiﬁcations of existing criteria, are better able to
predict longer-term outcome remains to be established. The
reliability of identifying such thresholds in clinical practice
is also less than in research settings,9 despite using widely
available tools.2 This is further complicated by concurrent
substance misuse, common in such clinical populations.
However, the deﬁnition and adoption of such thresholds is
clearly necessary to educate clinicians, decide when to
appropriately intervene and support research. The
complexity of the psychosis sub-syndrome groups
(including individuals with a family history of psychotic
illness, those with schizotypal disorder or the attenuated
psychosis syndrome, those with brief limited intermittent
notable severity psychotic episodes and those help-seeking
or not) and their undetermined probable outcomes may
lead to services primarily adopting a more discrete
threshold for inception, such as the DSM-5 research-
appendix-deﬁned attenuated psychosis syndrome, which
has marked clinical overlap with ARMS-deﬁned popula-
tions.9
Without clear diagnostic robustness of a condition, and
with a wide variation in clinical outcome, interpretation of
intervention studies is problematic. Initially, randomised
studies of diverse interventions for operationally deﬁned
ARMS (termed ultra high risk for psychosis) seemed to
show similar beneﬁcial effects v. control. Reviews pooling
outcomes of these studies clearly advocated intervention.7,10
More recent randomised studies have demonstrated less
clear beneﬁts over control than earlier studies, as is often
seen in health research (arguably ‘active’ controls were
used in many of these studies). Primary intervention
recommendations of supportive counselling/case manage-
ment for this clinical group have emerged, as previously
used as a control intervention. Several factors will need to
be considered, with future investigations including previous
low sample size due to recruitment problems, use of
robust and consistent thresholds for group inclusion, and
transition to psychosis to reduce heterogeneity of outcome,
consistent inclusion of functional outcomes, translation of
ﬁndings to usual clinical care (away from research clinics),
ensuring timely publication of results and the importance of
replication of existing ﬁndings.
While considerable progress has been made in this area,
we remain at the early stages of deﬁning a risk syndrome for
psychosis. The currently adopted clinical threshold for
ARMS seems to be a valid construct to identify clinical
need but the heterogeneity of subsequent clinical outcomes
is wide. Speciﬁc interventions for ARMS are unclear, aside
from those for commonly identiﬁed comorbidities (such as
anxiety, depression and substance misuse). Intervention
studies to date highlight the importance of methodological
rigour and consistency of diagnostic thresholds used, to
which end the DSM-5 attenuated psychosis syndrome may
be a positive step.9 Biological models for psychosis risk need
replication, clinical validation and combining with clinical
markers in larger, longitudinal studies to enhance risk
determination.2,11,12
Despite these caveats, this ﬁeld of study represents an
important advance in the development of preventive
psychiatry. The current move to incorporate earlier
psychosis states in more widespread clinical services, with
appropriate threshold deﬁnition and outcome monitoring,
may also have important societal impact.
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